Sponsor:
Emory University
Code:
NCT06674863
Conditions
Localized Prostate Carcinoma
Oligometastatic Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Educational Intervention
Interview
Questionnaire Administration
Supportive Care
Supportive Care
Brief summary:
Conditions
Localized Prostate Carcinoma
Oligometastatic Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8
Study ID
NCT06674863
Start date
Nov 7, 2025
Status verified date
Dec, 2025
Completion date
Dec 31, 2030
Anticipated
Primary completion date
Dec 31, 2029
Anticipated
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
150 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Group I (standard SCP, tailored SCP)
active comparator: Group II (standard SCP)
Interventions
Educational Intervention
Interview
Questionnaire Administration
Supportive Care
Supportive Care
Primary outcome measure
Central contacts
Locations
Grady Memorial Hospital
Recruiting
Atlanta, Georgia, United States, 30303
Contacts
Principal Investigator:
Viraj Master, MD, PhD, FACS
Emory University Hospital/Winship Cancer Institute
Recruiting
Atlanta, Georgia, United States, 30322
Contacts
Principal Investigator:
Viraj Master, MD, PhD, FACS
Atlanta VA Medical Center
Recruiting
Atlanta, Georgia, United States, 30329
Contacts
Principal Investigator:
Viraj Master, MD, PhD, FACS
Sponsor
Emory University
Last update posted
Dec 9, 2025
Last verified
Dec, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Emory University on 2025-12-09.